Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interval Bolus Delivery of Subcutaneous Hydrocortisone Via Infusion Pump in Children With Congenital Adrenal Hyperplasia

NCT03718234 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT03718234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03718234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interval Bolus Delivery of Subcutaneous Hydrocortisone Via Infusion Pump in Children With Congenital Adrenal Hyperplasia
Lead sponsor
University of Minnesota
Phase
Phase 1
Overall status
Completed
Start date
January 1, 2019
Completion date
February 23, 2023
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal gland disease, adrenal hyperplasia, adrenocortical hyperfunction, congenital adrenal hyperplasia, congenital disorders, disorders of sex development, genetic diseases, inborn, hydrocortisone, hyperplasia, steroid metabolic diseases, inborn, urogenital abnormalities